pyrazolanthrone has been researched along with Chromosomal Translocation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jaeschke, H; Lemasters, JJ; Saito, C | 1 |
| Barbetti, V; Dello Sbarba, P; Giuntoli, S; Gozzini, A; Rovida, E; Santini, V | 1 |
| Claret, FX; Drakos, E; Elenitoba-Johnson, KS; Leventaki, V; Lim, MS; Medeiros, LJ; Rassidakis, GZ | 1 |
3 other study(ies) available for pyrazolanthrone and Chromosomal Translocation
| Article | Year |
|---|---|
c-Jun N-terminal kinase modulates oxidant stress and peroxynitrite formation independent of inducible nitric oxide synthase in acetaminophen hepatotoxicity.
Topics: Acetaminophen; Alanine Transaminase; Analgesics, Non-Narcotic; Animals; Anthracenes; Apoptosis; bcl-2-Associated X Protein; Blotting, Western; Enzyme Activation; Enzyme Induction; JNK Mitogen-Activated Protein Kinases; Liver; Male; Mice; Mice, Inbred C57BL; Mitochondria, Liver; Nitric Oxide Synthase; Oxidative Stress; Peroxynitrous Acid; Phosphorylation; Reverse Transcriptase Polymerase Chain Reaction; Subcellular Fractions; Translocation, Genetic | 2010 |
The c-Jun-N-terminal-Kinase inhibitor SP600125 enhances the butyrate derivative D1-induced apoptosis via caspase 8 activation in Kasumi 1 t(8;21) acute myeloid leukaemia cells.
Topics: Anthracenes; Apoptosis; Blotting, Western; Butyrates; Caspase 8; Cell Line, Tumor; Chromosomes, Human, Pair 21; Chromosomes, Human, Pair 8; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; Flavonoids; Histone Deacetylase Inhibitors; Humans; Imidazoles; JNK Mitogen-Activated Protein Kinases; Leukemia, Myeloid, Acute; Mannose; p38 Mitogen-Activated Protein Kinases; Pyridines; Translocation, Genetic | 2006 |
NPM-ALK oncogenic kinase promotes cell-cycle progression through activation of JNK/cJun signaling in anaplastic large-cell lymphoma.
Topics: Anthracenes; Cell Cycle; Cell Transformation, Neoplastic; Chromosomes, Human, Pair 2; Chromosomes, Human, Pair 5; Cyclin A; Cyclin D3; Cyclins; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Activation; Humans; Jurkat Cells; Lymphoma, Large B-Cell, Diffuse; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinase 9; Oncogene Proteins, Fusion; p21-Activated Kinases; Phosphorylation; Protein Serine-Threonine Kinases; Protein-Tyrosine Kinases; Signal Transduction; Transcription Factor AP-1; Transcription, Genetic; Translocation, Genetic; Up-Regulation | 2007 |